France
WHO region
EURO
HIV prevalence
Low
Description
There is a policy allowing HIV self-testing. This policy is limited to in vitro diagnostic medical devices which are approved by the national regulatory authority (i.e. French National Agency for Medicines and Health Products). Two products for HIV self-testing have received national regulatory approval.
Policies explicitly allow HIVST
Yes
Policies under development
No
HIVST explicitly illegal
No
Legal situation
Authorized for use, sale and distribution
National policy
Studies related to this country
- Profile and motivations of people who are using the HIV self-test: results from the VIH: Teste-Toi Toi-meme study in France
- Dispensing HIV self-tests in pharmacies in France: the pharmacists' point of view
- Perceptions of and intentions to use a recently introduced blood-based HIV self-test in France
- Which information is given during the purchase of an HIV self-test in a Caen pharmacy? A comprehensive transversal and observational study usingsurveys, without modification of practice
- Sensitivity of the STAT-VIEW rapid self-test and implications for use during acute HIV infection
- Non-reactive HIV-1 self-tests after sustained viral suppression following early antiretroviral therapy
- Low feasibility rate of self-testing with a finger-stick whole blood test
- Internet-using men who have sex with men would be interested in accessing authorised HIV self-tests available for purchase online
- Access to and use of unauthorised online HIV self-tests by internet-using French-speaking men who have sex with men
- A finger-stick whole-blood HIV self-test as an HIV screening tool adapted to the general public
- Comparing the information and support needs of different population groups in preparation for 2015 government approval for HIV self-testing in France
- HIV self-test: perception and intention to use in a French nationwide study
